As of 2026-01-25, the Relative Valuation of Spectrum Pharmaceuticals Inc (SPPI) is (5.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.03 USD, the upside of Spectrum Pharmaceuticals Inc based on Relative Valuation is -634.7%.
The range of the Relative Valuation is (4.43) - (6.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 19.1x | 17.3x |
| Forward P/E multiples | 14.0x - 21.6x | 17.5x |
| Fair Price | (4.43) - (6.06) | (5.51) |
| Upside | -530.2% - -688.2% | -634.7% |
| Date | P/E |